WASHINGTON (Sputnik) - Nearly 70 percent of the US active duty service members have received at least one dose of coronavirus vaccines, Senior Adviser to the Secretary of Defence on COVID-19 Max Rose said on Wednesday.
“Over 68 percent of our active duty service members have received at least one [vaccine] dose”, Rose said during a briefing.
As per service branch, 77 percent of Navy, 70 percent of Army, 61 percent of Air Force and 58 percent of Marine Corps active duty personnel have been vaccinated with at least one dose.
The US Defence Department has also supported over 17 million vaccinations to Americans as well as additional 4 million to its personnel, Rose added.
According to the data compiled by the US Centres for Disease Control and Prevention, nearly 180 million of Americans have been vaccinated with at least one does while 155 million have been fully vaccinated.
Rose added that the Pentagon's COVID-19 task force will resume normal operations in the coming days.
"As the department continues to transition to fortify its pandemic preparedness, and to support vaccination efforts across the country and the globe, I could not be any more confident today that we are, as a Department [of Defence] and yes, as a nation, on a solid path", Rose said during a briefing. "In the coming days the functions of the COVID-19 task force will transition to normal operations."
Rose, the Pentagon chief's special adviser on COVID-19, underscored that the US Defence Department will continue to support fighting the pandemic until it is over on a global scale.
At the same time, acting Assistant US Defence Secretary for Health Affairs Terry Adirim said during the briefing that the new Delta variant of the novel coronavirus poses a threat to return no normal in the US as this more dangerous variant will soon become the predominant variant and is able to cause more serious disease in unvaccinated people than other virus mutations.
The Defence Department established the task force in 2020 to support other agencies efforts during the COVID-19 response.